179 related articles for article (PubMed ID: 37162717)
1. Trends in the epidemiology of Clostridioides difficile infection in Germany.
Vehreschild MJGT; Schreiber S; von Müller L; Epple HJ; Weinke T; Manthey C; Oh J; Wahler S; Stallmach A
Infection; 2023 Dec; 51(6):1695-1702. PubMed ID: 37162717
[TBL] [Abstract][Full Text] [Related]
2. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
3. [Legal Obligation to Notify Severe Clostridiodes difficile Infections - Data from Frankfurt am Main, Germany. Overview and Discussion].
Heudorf U; Berres M; Dogan O; Steul KS
Gesundheitswesen; 2022 Apr; 84(4):293-300. PubMed ID: 33588443
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of
Colomb-Cotinat M; Assouvie L; Durand J; Daniau C; Leon L; Maugat S; Soing-Altrach S; Gateau C; Couturier J; Arnaud I; Astagneau P; Berger-Carbonne A; Barbut F
Euro Surveill; 2019 Aug; 24(35):. PubMed ID: 31481147
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Pisapia R; Gärtner B; Berger FK; Reigadas E; Bouza E; Demont C; Wilcox MH
Anaerobe; 2020 Apr; 62():102178. PubMed ID: 32092415
[TBL] [Abstract][Full Text] [Related]
6. Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden.
Murphy CR; Avery TR; Dubberke ER; Huang SS
Infect Control Hosp Epidemiol; 2012 Jan; 33(1):20-8. PubMed ID: 22173518
[TBL] [Abstract][Full Text] [Related]
7. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
[TBL] [Abstract][Full Text] [Related]
8. Clostridioides difficile infection (CDI) during the COVID-19 pandemic.
Spigaglia P
Anaerobe; 2022 Apr; 74():102518. PubMed ID: 35063599
[TBL] [Abstract][Full Text] [Related]
9. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
10. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
[TBL] [Abstract][Full Text] [Related]
11. Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis.
Kazakova SV; Baggs J; McDonald LC; Yi SH; Hatfield KM; Guh A; Reddy SC; Jernigan JA
Clin Infect Dis; 2020 Jan; 70(1):11-18. PubMed ID: 30820545
[TBL] [Abstract][Full Text] [Related]
12. Costs Associated with the Treatment of Clostridioides Difficile Infections.
Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
[TBL] [Abstract][Full Text] [Related]
13. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.
Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM
Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561
[TBL] [Abstract][Full Text] [Related]
15. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
Yu H; Flaster N; Casanello AL; Curcio D
Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727
[TBL] [Abstract][Full Text] [Related]
16. Time trends and predictors of laboratory-confirmed recurrent and severe
Shaffer SR; Nugent Z; Walkty A; Yu BN; Lix LM; Targownik LE; Bernstein CN; Singh H
CMAJ Open; 2020; 8(4):E737-E746. PubMed ID: 33199507
[TBL] [Abstract][Full Text] [Related]
17. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
Adams DJ; Barone JB; Nylund CM
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
[TBL] [Abstract][Full Text] [Related]
18. Trends in facility-level rates of
Rose AN; Baggs J; Kazakova SV; Guh AY; Yi SH; McCarthy NL; Jernigan JA; Reddy SC
Infect Control Hosp Epidemiol; 2023 Feb; 44(2):238-245. PubMed ID: 35586888
[TBL] [Abstract][Full Text] [Related]
19. Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.
Alzouby S; Baig K; Alrabiah F; Shibl A; Al-Nakhli D; Senok AC
J Infect Public Health; 2020 Jul; 13(7):1012-1017. PubMed ID: 31831398
[TBL] [Abstract][Full Text] [Related]
20. Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection.
Merchante N; Chico P; Márquez-Saavedra E; Riera G; Herrero R; González-de-la-Aleja P; Aller AI; Rodríguez JC; Rodríguez-Fernández M; Ramos JM; Trigo-Rodríguez M; Merino E
Anaerobe; 2022 Jun; 75():102579. PubMed ID: 35500744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
